{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:49:01Z","timestamp":1793789341397,"version":"4.6.1"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200591"],"award-info":[{"award-number":["82200591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270562"],"award-info":[{"award-number":["82270562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Shandong Province","award":["ZR2025MS1260"],"award-info":[{"award-number":["ZR2025MS1260"]}]},{"name":"Development plan of Medicine and Health Science and Technology in Shandong Province","award":["202503030856"],"award-info":[{"award-number":["202503030856"]}]},{"name":"TCM science and technology development plan of Shandong Province","award":["M20254301"],"award-info":[{"award-number":["M20254301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02256-z","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:17:09Z","timestamp":1778059029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of DAP12 in immune-related inflammatory diseases"],"prefix":"10.1007","volume":"75","author":[{"given":"Jiaqi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2256_CR1","doi-asserted-by":"publisher","first-page":"1610662","DOI":"10.3389\/fimmu.2025.1610662","volume":"16","author":"H ElAbd","year":"2025","unstructured":"ElAbd H, Mahdy AKH. Decoding the etiology of immune-mediated inflammatory diseases statistically. Front Immunol. 2025;16:1610662. https:\/\/doi.org\/10.3389\/fimmu.2025.1610662.","journal-title":"Front Immunol"},{"key":"2256_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050793","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12050793.","journal-title":"Cells"},{"issue":"3","key":"2256_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20090516","volume":"207","author":"B Joyce-Shaikh","year":"2010","unstructured":"Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE, et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med. 2010;207(3):579\u201389. https:\/\/doi.org\/10.1084\/jem.20090516.","journal-title":"J Exp Med"},{"issue":"6","key":"2256_CR4","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1016\/s2665-9913(25)00091-8","volume":"7","author":"M Hagen","year":"2025","unstructured":"Hagen M, M\u00fcller F, Wirsching A, Kharboutli S, Spoerl S, D\u00fcsing C, et al. Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study. Lancet Rheumatol. 2025;7(6):e424\u201333. https:\/\/doi.org\/10.1016\/s2665-9913(25)00091-8.","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"2256_CR5","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monz\u00f3n-Sandoval J, et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain. 2019;142(10):3243\u201364. https:\/\/doi.org\/10.1093\/brain\/awz241.","journal-title":"Brain"},{"issue":"1","key":"2256_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1600-065X.2009.00841.x","volume":"232","author":"JA Hamerman","year":"2009","unstructured":"Hamerman JA, Ni M, Killebrew JR, Chu CL, Lowell CA. The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells. Immunol Rev. 2009;232(1):42\u201358. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00841.x.","journal-title":"Immunol Rev"},{"issue":"6668","key":"2256_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/35642","volume":"391","author":"LL Lanier","year":"1998","unstructured":"Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 1998;391(6668):703\u20137. https:\/\/doi.org\/10.1038\/35642.","journal-title":"Nature"},{"issue":"11","key":"2256_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/ni.1943","volume":"11","author":"ME Call","year":"2010","unstructured":"Call ME, Wucherpfennig KW, Chou JJ. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol. 2010;11(11):1023\u20139. https:\/\/doi.org\/10.1038\/ni.1943.","journal-title":"Nat Immunol"},{"issue":"2","key":"2256_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nri2014","volume":"7","author":"IR Turnbull","year":"2007","unstructured":"Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol. 2007;7(2):155\u201361. https:\/\/doi.org\/10.1038\/nri2014.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2256_CR10","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/1521-4141(200209)32:9<2653::Aid-immu2653>3.0.Co;2-v","volume":"32","author":"M Lucas","year":"2002","unstructured":"Lucas M, Daniel L, Tomasello E, Guia S, Horschowski N, Aoki N, et al. Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP\/DAP12-transgenic mice. Eur J Immunol. 2002;32(9):2653\u201363. https:\/\/doi.org\/10.1002\/1521-4141(200209)32:9%3c2653::Aid-immu2653%3e3.0.Co;2-v.","journal-title":"Eur J Immunol"},{"issue":"51","key":"2256_CR11","doi-asserted-by":"publisher","first-page":"34115","DOI":"10.1074\/jbc.273.51.34115","volume":"273","author":"E Tomasello","year":"1998","unstructured":"Tomasello E, Olcese L, V\u00e9ly F, Geourgeon C, Bl\u00e9ry M, Moqrich A, et al. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)\/DAP-12 *. J Biol Chem. 1998;273(51):34115\u20139. https:\/\/doi.org\/10.1074\/jbc.273.51.34115.","journal-title":"J Biol Chem"},{"key":"2256_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.0105-2896.2005.00325.x","volume":"208","author":"MB Humphrey","year":"2005","unstructured":"Humphrey MB, Lanier LL, Nakamura MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005;208:50\u201365. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00325.x.","journal-title":"Immunol Rev"},{"issue":"1","key":"2256_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00018-024-05298-w","volume":"81","author":"Y Liu","year":"2024","unstructured":"Liu Y, Theil S, Ibach M, Walter J. DAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2. Cell Mol Life Sci. 2024;81(1):302. https:\/\/doi.org\/10.1007\/s00018-024-05298-w.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2256_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-065X.2008.00720.x","volume":"227","author":"LL Lanier","year":"2009","unstructured":"Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev. 2009;227(1):150\u201360. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00720.x.","journal-title":"Immunol Rev"},{"key":"2256_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/jir.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res. 2022;15:3083\u201394. https:\/\/doi.org\/10.2147\/jir.S350109.","journal-title":"J Inflamm Res"},{"issue":"12","key":"2256_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/s0167-5699(00)01745-x","volume":"21","author":"LL Lanier","year":"2000","unstructured":"Lanier LL, Bakker AB. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today. 2000;21(12):611\u20134. https:\/\/doi.org\/10.1016\/s0167-5699(00)01745-x.","journal-title":"Immunol Today"},{"issue":"6","key":"2256_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/s1357-2725(99)00022-9","volume":"31","author":"KS Campbell","year":"1999","unstructured":"Campbell KS, Colonna M. DAP12: a key accessory protein for relaying signals by natural killer cell receptors. Int J Biochem Cell Biol. 1999;31(6):631\u20136. https:\/\/doi.org\/10.1016\/s1357-2725(99)00022-9.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2256_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/ni.1706","volume":"10","author":"LB Ivashkiv","year":"2009","unstructured":"Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol. 2009;10(4):340\u20137. https:\/\/doi.org\/10.1038\/ni.1706.","journal-title":"Nat Immunol"},{"issue":"6832","key":"2256_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/35074114","volume":"410","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103\u20137. https:\/\/doi.org\/10.1038\/35074114.","journal-title":"Nature"},{"issue":"1","key":"2256_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.autrev.2018.07.008","volume":"18","author":"S Gao","year":"2019","unstructured":"Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev. 2019;18(1):25\u201335. https:\/\/doi.org\/10.1016\/j.autrev.2018.07.008.","journal-title":"Autoimmun Rev"},{"key":"2256_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.766178","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Zeng H, Xu C, Chen H, Fan L, Zhou H, et al. TREM1 regulates neuroinflammatory injury by modulate proinflammatory subtype transition of microglia and formation of neutrophil extracellular traps via interaction with SYK in experimental subarachnoid hemorrhage. Front Immunol. 2021;12:766178. https:\/\/doi.org\/10.3389\/fimmu.2021.766178.","journal-title":"Front Immunol"},{"issue":"1","key":"2256_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-025-02155-9","volume":"75","author":"X Zhou","year":"2025","unstructured":"Zhou X, Liu Z, Li S, Yu S, Sun M, Si Z, et al. TREM2-driven peripheral macrophage regulation in inflammatory diseases: implications extending beyond neurological disorders. Inflamm Res. 2025;75(1):5. https:\/\/doi.org\/10.1007\/s00011-025-02155-9.","journal-title":"Inflamm Res"},{"key":"2256_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112042","volume":"134","author":"S Bharadwaj","year":"2024","unstructured":"Bharadwaj S, Groza Y, Mierzwicka JM, Mal\u00fd P. Current understanding on TREM-2 molecular biology and physiopathological functions. Int Immunopharmacol. 2024;134:112042. https:\/\/doi.org\/10.1016\/j.intimp.2024.112042.","journal-title":"Int Immunopharmacol"},{"issue":"289","key":"2256_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003801","volume":"6","author":"Q Peng","year":"2013","unstructured":"Peng Q, Long CL, Malhotra S, Humphrey MB. A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages. Sci Signal. 2013;6(289):ra72. https:\/\/doi.org\/10.1126\/scisignal.2003801.","journal-title":"Sci Signal"},{"issue":"1","key":"2256_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01853-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, et al. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2020;17(1):168. https:\/\/doi.org\/10.1186\/s12974-020-01853-x.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2256_CR26","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.7150\/ijbs.91519","volume":"20","author":"C Fang","year":"2024","unstructured":"Fang C, Zhong R, Lu S, Yu G, Liu Z, Yan C, et al. TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-\u03baB\/CXCL3 axis. Int J Biol Sci. 2024;20(6):1992\u20132007. https:\/\/doi.org\/10.7150\/ijbs.91519.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2256_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cbin.10975","volume":"43","author":"C Li","year":"2019","unstructured":"Li C, Zhao B, Lin C, Gong Z, An X. TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K\/NF-\u03baB signaling. Cell Biol Int. 2019;43(4):360\u201372. https:\/\/doi.org\/10.1002\/cbin.10975.","journal-title":"Cell Biol Int"},{"issue":"8","key":"2256_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/glycob\/cwm049","volume":"17","author":"T Angata","year":"2007","unstructured":"Angata T, Tabuchi Y, Nakamura K, Nakamura M. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution. Glycobiology. 2007;17(8):838\u201346. https:\/\/doi.org\/10.1093\/glycob\/cwm049.","journal-title":"Glycobiology"},{"issue":"21","key":"2256_CR29","doi-asserted-by":"publisher","first-page":"17493","DOI":"10.1074\/jbc.M111.324194","volume":"287","author":"N Ishida-Kitagawa","year":"2012","unstructured":"Ishida-Kitagawa N, Tanaka K, Bao X, Kimura T, Miura T, Kitaoka Y, et al. Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12). J Biol Chem. 2012;287(21):17493\u2013502. https:\/\/doi.org\/10.1074\/jbc.M111.324194.","journal-title":"J Biol Chem"},{"issue":"17","key":"2256_CR30","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1073\/pnas.96.17.9792","volume":"96","author":"AB Bakker","year":"1999","unstructured":"Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A. 1999;96(17):9792\u20136. https:\/\/doi.org\/10.1073\/pnas.96.17.9792.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2256_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00356-3","volume":"8","author":"ST Chen","year":"2017","unstructured":"Chen ST, Li FJ, Hsu TY, Liang SM, Yeh YC, Liao WY, et al. CLEC5A is a critical receptor in innate immunity against Listeria infection. Nat Commun. 2017;8(1):299. https:\/\/doi.org\/10.1038\/s41467-017-00356-3.","journal-title":"Nat Commun"},{"issue":"8","key":"2256_CR32","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.42478","volume":"75","author":"H Furuya","year":"2023","unstructured":"Furuya H, Nguyen CT, Gu R, Hsieh SL, Maverakis E, Adamopoulos IE. Interleukin-23 regulates inflammatory osteoclastogenesis via activation of CLEC5A(+) osteoclast precursors. Arthritis Rheumatol. 2023;75(8):1477\u201389. https:\/\/doi.org\/10.1002\/art.42478.","journal-title":"Arthritis Rheumatol"},{"key":"2256_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fimmu.2012.00326","volume":"3","author":"C K\u00f6rner","year":"2012","unstructured":"K\u00f6rner C, Altfeld M. Role of KIR3DS1 in human diseases. Front Immunol. 2012;3:326. https:\/\/doi.org\/10.3389\/fimmu.2012.00326.","journal-title":"Front Immunol"},{"key":"2256_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071777","author":"J D\u0119bska-Zielkowska","year":"2021","unstructured":"D\u0119bska-Zielkowska J, Moszkowska G, Zieli\u0144ski M, Zieli\u0144ska H, Dukat-Mazurek A, Trzonkowski P, et al. KIR receptors as key regulators of NK cells activity in health and disease. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10071777.","journal-title":"Cells"},{"issue":"9","key":"2256_CR35","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.celrep.2016.04.075","volume":"15","author":"A Oszmiana","year":"2016","unstructured":"Oszmiana A, Williamson DJ, Cordoba SP, Morgan DJ, Kennedy PR, Stacey K, et al. The size of activating and inhibitory killer Ig-like receptor nanoclusters Is controlled by the transmembrane sequence and affects Signaling. Cell Rep. 2016;15(9):1957\u201372. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.075.","journal-title":"Cell Rep"},{"key":"2256_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136670","author":"E Pra\u0161nikar","year":"2021","unstructured":"Pra\u0161nikar E, Perdih A, Bori\u0161ek J. Nonameric peptide orchestrates signal transduction in the activating HLA-E\/NKG2C\/CD94 immune complex as revealed by all-atom simulations. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22136670.","journal-title":"Int J Mol Sci"},{"issue":"90","key":"2256_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi3974","volume":"8","author":"S Jost","year":"2023","unstructured":"Jost S, Lucar O, Lee E, Yoder T, Kroll K, Sugawara S, et al. Antigen-specific memory NK cell responses against HIV and influenza use the NKG2\/HLA-E axis. Sci Immunol. 2023;8(90):eadi3974. https:\/\/doi.org\/10.1126\/sciimmunol.adi3974.","journal-title":"Sci Immunol"},{"issue":"5","key":"2256_CR38","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.189.5.787","volume":"189","author":"C Cantoni","year":"1999","unstructured":"Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 1999;189(5):787\u201396. https:\/\/doi.org\/10.1084\/jem.189.5.787.","journal-title":"J Exp Med"},{"key":"2256_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197\u2013223. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.197.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"2256_CR40","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nri3087","volume":"11","author":"A Chow","year":"2011","unstructured":"Chow A, Brown BD, Merad M. Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol. 2011;11(11):788\u201398. https:\/\/doi.org\/10.1038\/nri3087.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2256_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1084\/jem.20050986","volume":"202","author":"IR Turnbull","year":"2005","unstructured":"Turnbull IR, McDunn JE, Takai T, Townsend RR, Cobb JP, Colonna M. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J Exp Med. 2005;202(3):363\u20139. https:\/\/doi.org\/10.1084\/jem.20050986.","journal-title":"J Exp Med"},{"key":"2256_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.molimm.2025.08.006","volume":"186","author":"S Sun","year":"2025","unstructured":"Sun S, Yi R, Wang X, Zhang Y, Liu M, Wang L, et al. DAP12 affects the acute inflammatory response caused by UPEC or LPS by regulating macrophage infiltration. Mol Immunol. 2025;186:124\u201332. https:\/\/doi.org\/10.1016\/j.molimm.2025.08.006.","journal-title":"Mol Immunol"},{"key":"2256_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107212","volume":"204","author":"C Li","year":"2024","unstructured":"Li C, Cai C, Xu D, Chen X, Song J. TREM1: activation, signaling, cancer and therapy. Pharmacol Res. 2024;204:107212. https:\/\/doi.org\/10.1016\/j.phrs.2024.107212.","journal-title":"Pharmacol Res"},{"issue":"10","key":"2256_CR44","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991\u20135. https:\/\/doi.org\/10.4049\/jimmunol.164.10.4991.","journal-title":"J Immunol"},{"issue":"1","key":"2256_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10753-016-0448-6","volume":"40","author":"L Dong","year":"2017","unstructured":"Dong L, Zhou Y, Zhu ZQ, Liu T, Duan JX, Zhang J, et al. Soluble epoxide hydrolase inhibitor suppresses the expression of triggering receptor expressed on myeloid cells-1 by inhibiting NF-kB activation in murine macrophage. Inflammation. 2017;40(1):13\u201320. https:\/\/doi.org\/10.1007\/s10753-016-0448-6.","journal-title":"Inflammation"},{"issue":"1","key":"2256_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7150\/ijms.50893","volume":"18","author":"P Pan","year":"2021","unstructured":"Pan P, Liu X, Wu L, Li X, Wang K, Wang X, et al. TREM-1 promoted apoptosis and inhibited autophagy in LPS-treated HK-2 cells through the NF-\u03baB pathway. Int J Med Sci. 2021;18(1):8\u201317. https:\/\/doi.org\/10.7150\/ijms.50893.","journal-title":"Int J Med Sci"},{"key":"2256_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115116","author":"XH Chen","year":"2015","unstructured":"Chen XH, Eksioglu EA, Carter JD, Fortenbery N, Donatelli SS, Zhou JM, et al. Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in Rheumatoid Arthritis. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0115116.","journal-title":"PLoS ONE"},{"issue":"5","key":"2256_CR48","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.4049\/jimmunol.180.5.3520","volume":"180","author":"K Dower","year":"2008","unstructured":"Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol. 2008;180(5):3520\u201334. https:\/\/doi.org\/10.4049\/jimmunol.180.5.3520.","journal-title":"J Immunol"},{"issue":"1","key":"2256_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/ijbs.77304","volume":"19","author":"WJ Zhong","year":"2023","unstructured":"Zhong WJ, Liu T, Yang HH, Duan JX, Yang JT, Guan XX, et al. TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury. Int J Biol Sci. 2023;19(1):242\u201357. https:\/\/doi.org\/10.7150\/ijbs.77304.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"2256_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41423-018-0003-5","volume":"16","author":"K Carrasco","year":"2019","unstructured":"Carrasco K, Boufenzer A, Jolly L, Le Cordier H, Wang G, Heck AJ, et al. TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cell Mol Immunol. 2019;16(5):460\u201372. https:\/\/doi.org\/10.1038\/s41423-018-0003-5.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"2256_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ni1204","volume":"6","author":"JA Hamerman","year":"2005","unstructured":"Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol. 2005;6(6):579\u201386. https:\/\/doi.org\/10.1038\/ni1204.","journal-title":"Nat Immunol"},{"issue":"4","key":"2256_CR52","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","volume":"177","author":"JA Hamerman","year":"2006","unstructured":"Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 2006;177(4):2051\u20135. https:\/\/doi.org\/10.4049\/jimmunol.177.4.2051.","journal-title":"J Immunol"},{"issue":"1","key":"2256_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00550-y","volume":"17","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang LL, Fan X, Ku Z, Li L, et al. LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions. Mol Neurodegener. 2022;17(1):44. https:\/\/doi.org\/10.1186\/s13024-022-00550-y.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2256_CR54","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.20101623","volume":"208","author":"T Nakano-Yokomizo","year":"2011","unstructured":"Nakano-Yokomizo T, Tahara-Hanaoka S, Nakahashi-Oda C, Nabekura T, Tchao NK, Kadosaki M, et al. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med. 2011;208(8):1661\u201371. https:\/\/doi.org\/10.1084\/jem.20101623.","journal-title":"J Exp Med"},{"issue":"12","key":"2256_CR55","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1172\/jci97570","volume":"128","author":"HM Chen","year":"2018","unstructured":"Chen HM, van der Touw W, Wang YS, Kang K, Mai S, Zhang J, et al. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity. J Clin Invest. 2018;128(12):5647\u201362. https:\/\/doi.org\/10.1172\/jci97570.","journal-title":"J Clin Invest"},{"issue":"2","key":"2256_CR56","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","volume":"179","author":"M Prinz","year":"2019","unstructured":"Prinz M, Jung S, Priller J. Microglia biology: one century of evolving concepts. Cell. 2019;179(2):292\u2013311. https:\/\/doi.org\/10.1016\/j.cell.2019.08.053.","journal-title":"Cell"},{"issue":"2","key":"2256_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/1744666x.2014.866519","volume":"10","author":"CJ Pelham","year":"2014","unstructured":"Pelham CJ, Agrawal DK. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(2):243\u201356. https:\/\/doi.org\/10.1586\/1744666x.2014.866519.","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"2256_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114788","volume":"43","author":"M Pizzuto","year":"2024","unstructured":"Pizzuto M, Hurtado-Navarro L, Molina-Lopez C, Soubhye J, Gelbcke M, Rodriguez-Lopez S, et al. Ornithine lipid is a partial TLR4 agonist and NLRP3 activator. Cell Rep. 2024;43(10):114788. https:\/\/doi.org\/10.1016\/j.celrep.2024.114788.","journal-title":"Cell Rep"},{"issue":"1","key":"2256_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s44477-025-00012-x","volume":"2","author":"GE Farias Quipildor","year":"2026","unstructured":"Farias Quipildor GE, Belfiore R, Althobaiti K, Najarzadeh Z, Glabe C, Readhead BP, et al. Differential downstream signaling in microglia lacking Alzheimer\u2019s-related TREM2 or its adaptor TYROBP\/DAP12. Mol Neurodegener Adv. 2026;2(1):8. https:\/\/doi.org\/10.1186\/s44477-025-00012-x.","journal-title":"Mol Neurodegener Adv"},{"key":"2256_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2017.00204","volume":"9","author":"L Zhong","year":"2017","unstructured":"Zhong L, Zhang ZL, Li X, Liao C, Mou P, Wang T, et al. TREM2\/DAP12 complex regulates inflammatory responses in microglia via the JNK Signaling pathway. Front Aging Neurosci. 2017;9:204. https:\/\/doi.org\/10.3389\/fnagi.2017.00204.","journal-title":"Front Aging Neurosci"},{"key":"2256_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2020.10.006","volume":"166","author":"X Cui","year":"2021","unstructured":"Cui X, Qiao J, Liu S, Wu M, Gu W. Mechanism of TREM2\/DAP12 complex affecting \u03b2-amyloid plaque deposition in Alzheimer\u2019s disease modeled mice through mediating inflammatory response. Brain Res Bull. 2021;166:21\u20138. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.006.","journal-title":"Brain Res Bull"},{"issue":"25","key":"2256_CR62","doi-asserted-by":"publisher","first-page":"15866","DOI":"10.1074\/jbc.M115.645986","volume":"290","author":"L Zhong","year":"2015","unstructured":"Zhong L, Chen XF, Zhang ZL, Wang Z, Shi XZ, Xu K, et al. DAP12 stabilizes the C-terminal fragment of the triggering receptor Expressed on myeloid cells-2 (TREM2) and protects against LPS-induced Pro-inflammatory response. J Biol Chem. 2015;290(25):15866\u201377. https:\/\/doi.org\/10.1074\/jbc.M115.645986.","journal-title":"J Biol Chem"},{"issue":"19","key":"2256_CR63","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","volume":"29","author":"WF Liu","year":"2020","unstructured":"Liu WF, Taso O, Wang R, Bayram S, Graham AC, Garcia-Reitboeck P, et al. Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum Mol Genet. 2020;29(19):3224\u201348. https:\/\/doi.org\/10.1093\/hmg\/ddaa209.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2256_CR64","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","volume":"177","author":"IR Turnbull","year":"2006","unstructured":"Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 2006;177(6):3520\u20134. https:\/\/doi.org\/10.4049\/jimmunol.177.6.3520.","journal-title":"J Immunol"},{"issue":"1","key":"2256_CR65","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/s41467-021-22620-3","volume":"12","author":"E Iizasa","year":"2021","unstructured":"Iizasa E, Chuma Y, Uematsu T, Kubota M, Kawaguchi H, Umemura M, et al. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun. 2021;12(1):2299. https:\/\/doi.org\/10.1038\/s41467-021-22620-3.","journal-title":"Nat Commun"},{"issue":"4","key":"2256_CR66","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201(4):647\u201357. https:\/\/doi.org\/10.1084\/jem.20041611.","journal-title":"J Exp Med"},{"key":"2256_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fncel.2019.00457","volume":"13","author":"H Yao","year":"2019","unstructured":"Yao H, Coppola K, Schweig JE, Crawford F, Mullan M, Paris D. Distinct signaling pathways regulate TREM2 Phagocytic and NF\u03baB antagonistic activities. Front Cell Neurosci. 2019;13:457. https:\/\/doi.org\/10.3389\/fncel.2019.00457.","journal-title":"Front Cell Neurosci"},{"key":"2256_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123377","volume":"322","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yu T, Xiang Q, van den Tillaart F, Ma J, Zhuang Z, et al. Osteoclasts drive bone formation in ectopic and orthotopic environments. Biomaterials. 2025;322:123377. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123377.","journal-title":"Biomaterials"},{"issue":"16","key":"2256_CR69","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1073\/pnas.0401602101","volume":"101","author":"A M\u00f3csai","year":"2004","unstructured":"M\u00f3csai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004;101(16):6158\u201363. https:\/\/doi.org\/10.1073\/pnas.0401602101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2256_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-024-00788-w","volume":"30","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu Y, Deng Y, Li Y, Liu S, Yang Y, et al. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. Mol Med. 2024;30(1):20. https:\/\/doi.org\/10.1186\/s10020-024-00788-w.","journal-title":"Mol Med"},{"issue":"6","key":"2256_CR71","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3(6):889\u2013901. https:\/\/doi.org\/10.1016\/s1534-5807(02)00369-6.","journal-title":"Dev Cell"},{"issue":"5","key":"2256_CR72","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jbmr.1561","volume":"27","author":"Y Lee","year":"2012","unstructured":"Lee Y, Kim HJ, Park CK, Kim WS, Lee ZH, Kim HH. Novel extraneural role of neurite outgrowth inhibitor A: modulation of osteoclastogenesis via positive feedback regulation of nuclear factor of activated T cell cytoplasmic 1. J Bone Miner Res. 2012;27(5):1043\u201354. https:\/\/doi.org\/10.1002\/jbmr.1561.","journal-title":"J Bone Miner Res"},{"issue":"6984","key":"2256_CR73","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature02444","volume":"428","author":"T Koga","year":"2004","unstructured":"Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004;428(6984):758\u201363. https:\/\/doi.org\/10.1038\/nature02444.","journal-title":"Nature"},{"issue":"6","key":"2256_CR74","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1083\/jcb.200611083","volume":"176","author":"W Zou","year":"2007","unstructured":"Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, et al. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol. 2007;176(6):877\u201388. https:\/\/doi.org\/10.1083\/jcb.200611083.","journal-title":"J Cell Biol"},{"issue":"4","key":"2256_CR75","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20030027","volume":"198","author":"J Paloneva","year":"2003","unstructured":"Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, Hakola P, et al. DAP12\/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med. 2003;198(4):669\u201375. https:\/\/doi.org\/10.1084\/jem.20030027.","journal-title":"J Exp Med"},{"key":"2256_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101849","volume":"40","author":"Y Weng","year":"2021","unstructured":"Weng Y, Wang H, Li L, Feng Y, Xu S, Wang Z. Trem2 mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment. Redox Biol. 2021;40:101849. https:\/\/doi.org\/10.1016\/j.redox.2020.101849.","journal-title":"Redox Biol"},{"issue":"122","key":"2256_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3(122):ra38. https:\/\/doi.org\/10.1126\/scisignal.2000500.","journal-title":"Sci Signal"},{"issue":"Pt 17","key":"2256_CR78","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1242\/jcs.069872","volume":"123","author":"W Zou","year":"2010","unstructured":"Zou W, Zhu T, Craft CS, Broekelmann TJ, Mecham RP, Teitelbaum SL. Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts. J Cell Sci. 2010;123(Pt 17):2955\u201363. https:\/\/doi.org\/10.1242\/jcs.069872.","journal-title":"J Cell Sci"},{"issue":"12","key":"2256_CR79","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/jbmr.1989","volume":"28","author":"Y Kameda","year":"2013","unstructured":"Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, et al. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling adaptor DAP12. J Bone Miner Res. 2013;28(12):2463\u201375. https:\/\/doi.org\/10.1002\/jbmr.1989.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2256_CR80","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/ptr.8456","volume":"39","author":"Y Wu","year":"2025","unstructured":"Wu Y, Yin M, Xia W, Dou B, Liu X, Sun R. Enhancing NK cell antitumor activity with natural compounds: research advances and molecular mechanisms. Phytother Res. 2025;39(5):1905\u201329. https:\/\/doi.org\/10.1002\/ptr.8456.","journal-title":"Phytother Res"},{"key":"2256_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02022","volume":"11","author":"F Gao","year":"2020","unstructured":"Gao F, Ye Y, Gao Y, Huang H, Zhao Y. Influence of KIR and NK cell reconstitution in the outcomes of hematopoietic stem cell transplantation. Front Immunol. 2020;11:2022. https:\/\/doi.org\/10.3389\/fimmu.2020.02022.","journal-title":"Front Immunol"},{"issue":"5","key":"2256_CR82","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","volume":"16","author":"S Sivori","year":"2019","unstructured":"Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol. 2019;16(5):430\u201341. https:\/\/doi.org\/10.1038\/s41423-019-0206-4.","journal-title":"Cell Mol Immunol"},{"key":"2256_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171464","author":"V Im\u0161irovi\u0107","year":"2024","unstructured":"Im\u0161irovi\u0107 V, Wensveen FM, Poli\u0107 B, Jelen\u010di\u0107 V. Maintaining the balance: regulation of NK cell activity. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13171464.","journal-title":"Cells"},{"key":"2256_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00283","volume":"10","author":"F Gabor","year":"2020","unstructured":"Gabor F, Jahn G, Sedmak DD, Sinzger C. In vivo downregulation of MHC Class I molecules by HCMV occurs during all phases of viral replication but is not always complete. Front Cell Infect Microbiol. 2020;10:283. https:\/\/doi.org\/10.3389\/fcimb.2020.00283.","journal-title":"Front Cell Infect Microbiol"},{"key":"2256_CR85","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol. 2013;31:413\u201341. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095951.","journal-title":"Annu Rev Immunol"},{"issue":"5571","key":"2256_CR86","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1070884","volume":"296","author":"H Arase","year":"2002","unstructured":"Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296(5571):1323\u20136. https:\/\/doi.org\/10.1126\/science.1070884.","journal-title":"Science"},{"key":"2256_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00145","volume":"5","author":"MM Rahim","year":"2014","unstructured":"Rahim MM, Tu MM, Mahmoud AB, Wight A, Abou-Samra E, Lima PD, et al. Ly49 receptors: innate and adaptive immune paradigms. Front Immunol. 2014;5:145. https:\/\/doi.org\/10.3389\/fimmu.2014.00145.","journal-title":"Front Immunol"},{"issue":"4","key":"2256_CR88","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.immuni.2008.07.014","volume":"29","author":"ME Peterson","year":"2008","unstructured":"Peterson ME, Long EO. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity. 2008;29(4):578\u201388. https:\/\/doi.org\/10.1016\/j.immuni.2008.07.014.","journal-title":"Immunity"},{"issue":"1","key":"2256_CR89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/immunohorizons.2300099","volume":"8","author":"N Diwanji","year":"2024","unstructured":"Diwanji N, Getts D, Wang Y. Chimeric antigen cytotoxic receptors for In vivo engineering of tumor-targeting NK cells. Immunohorizons. 2024;8(1):97\u2013105. https:\/\/doi.org\/10.4049\/immunohorizons.2300099.","journal-title":"Immunohorizons"},{"issue":"7","key":"2256_CR90","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.4049\/jimmunol.1400330","volume":"194","author":"K T\u00f6pfer","year":"2015","unstructured":"T\u00f6pfer K, Cartellieri M, Michen S, Wiedemuth R, M\u00fcller N, Lindemann D, et al. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy. J Immunol. 2015;194(7):3201\u201312. https:\/\/doi.org\/10.4049\/jimmunol.1400330.","journal-title":"J Immunol"},{"issue":"6","key":"2256_CR91","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1128\/jvi.02614-15","volume":"90","author":"KC Chen","year":"2016","unstructured":"Chen KC, Stanton RJ, Banat JJ, Wills MR. Leukocyte immunoglobulin-like receptor 1-expressing human natural killer cell subsets differentially recognize isolates of human Cytomegalovirus through the viral major histocompatibility complex class I homolog UL18. J Virol. 2016;90(6):3123\u201337. https:\/\/doi.org\/10.1128\/jvi.02614-15.","journal-title":"J Virol"},{"issue":"12","key":"2256_CR92","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.4049\/jimmunol.1102345","volume":"187","author":"PC Saether","year":"2011","unstructured":"Saether PC, Hoelsbrekken SE, Fossum S, Dissen E. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity. J Immunol. 2011;187(12):6365\u201373. https:\/\/doi.org\/10.4049\/jimmunol.1102345.","journal-title":"J Immunol"},{"issue":"1","key":"2256_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.molimm.2004.01.004","volume":"41","author":"DK Kim","year":"2004","unstructured":"Kim DK, Kabat J, Borrego F, Sanni TB, You CH, Coligan JE. Human NKG2F is expressed and can associate with DAP12. Mol Immunol. 2004;41(1):53\u201362. https:\/\/doi.org\/10.1016\/j.molimm.2004.01.004.","journal-title":"Mol Immunol"},{"issue":"12","key":"2256_CR94","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1172\/jci77440","volume":"124","author":"A R\u00f6lle","year":"2014","unstructured":"R\u00f6lle A, Pollmann J, Ewen EM, Le VT, Halenius A, Hengel H, et al. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest. 2014;124(12):5305\u201316. https:\/\/doi.org\/10.1172\/jci77440.","journal-title":"J Clin Invest"},{"key":"2256_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061454","author":"WC Pump","year":"2019","unstructured":"Pump WC, Kraemer T, Huyton T, H\u00f2 GT, Blasczyk R, Bade-Doeding C. Between innate and adaptive immune responses: NKG2A, NKG2C, and CD8\u207a T cell recognition of HLA-E restricted self-peptides acquired in the absence of HLA-Ia. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20061454.","journal-title":"Int J Mol Sci"},{"key":"2256_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.182660","author":"N S\u00e1nchez-Gaona","year":"2024","unstructured":"S\u00e1nchez-Gaona N, Gallego-Cort\u00e9s A, Astorga-Gamaza A, Rall\u00f3n N, Benito JM, Ruiz-Mateos E, et al. NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.182660.","journal-title":"JCI Insight"},{"key":"2256_CR97","doi-asserted-by":"publisher","first-page":"1230718","DOI":"10.3389\/fimmu.2023.1230718","volume":"14","author":"N Mart\u00edn Almaz\u00e1n","year":"2023","unstructured":"Mart\u00edn Almaz\u00e1n N, Sala BM, Sandalova T, Sun Y, Resink T, Cichocki F, et al. Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses. Front Immunol. 2023;14:1230718. https:\/\/doi.org\/10.3389\/fimmu.2023.1230718.","journal-title":"Front Immunol"},{"issue":"11","key":"2256_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32622","volume":"10","author":"S Okpoluaefe","year":"2024","unstructured":"Okpoluaefe S, Ismail IS, Mohamed R, Hassan N. Adaptive natural killer cell expression in response to cytomegalovirus infection in blood and solid cancer. Heliyon. 2024;10(11):e32622. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32622.","journal-title":"Heliyon"},{"issue":"7","key":"2256_CR99","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20011427","volume":"195","author":"H Sj\u00f6lin","year":"2002","unstructured":"Sj\u00f6lin H, Tomasello E, Mousavi-Jazi M, Bartolazzi A, K\u00e4rre K, Vivier E, et al. Pivotal role of KARAP\/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med. 2002;195(7):825\u201334. https:\/\/doi.org\/10.1084\/jem.20011427.","journal-title":"J Exp Med"},{"issue":"8","key":"2256_CR100","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.4049\/jimmunol.177.8.4981","volume":"177","author":"AR French","year":"2006","unstructured":"French AR, Sj\u00f6lin H, Kim S, Koka R, Yang L, Young DA, et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol. 2006;177(8):4981\u201390. https:\/\/doi.org\/10.4049\/jimmunol.177.8.4981.","journal-title":"J Immunol"},{"issue":"2","key":"2256_CR101","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4049\/jimmunol.172.2.899","volume":"172","author":"KS Campbell","year":"2004","unstructured":"Campbell KS, Yusa S, Kikuchi-Maki A, Catina TL. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J Immunol. 2004;172(2):899\u2013906. https:\/\/doi.org\/10.4049\/jimmunol.172.2.899.","journal-title":"J Immunol"},{"issue":"9","key":"2256_CR102","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/jci45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121(9):3609\u201322. https:\/\/doi.org\/10.1172\/jci45816.","journal-title":"J Clin Invest"},{"issue":"3","key":"2256_CR103","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","volume":"172","author":"AD Barrow","year":"2018","unstructured":"Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, et al. Natural killer cells control tumor growth by sensing a growth factor. Cell. 2018;172(3):534-48.e19. https:\/\/doi.org\/10.1016\/j.cell.2017.11.037.","journal-title":"Cell"},{"key":"2256_CR104","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/b978-0-444-52001-2.00008-x","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol. 2014;122:173\u201389. https:\/\/doi.org\/10.1016\/b978-0-444-52001-2.00008-x.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"2256_CR105","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.immuni.2025.09.007","volume":"58","author":"M Benamar","year":"2025","unstructured":"Benamar M, Contini P, Schmitz-Abe K, Lanzetta O, Getachew F, Bachelin C, et al. Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis. Immunity. 2025;58(11):2753-68.e6. https:\/\/doi.org\/10.1016\/j.immuni.2025.09.007.","journal-title":"Immunity"},{"issue":"1","key":"2256_CR106","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","volume":"42","author":"F Navabi","year":"2019","unstructured":"Navabi F, Shaygannejad V, Abbasirad F, Vaez E, Hosseininasab F, Kazemi M, et al. Immunoregulatory effects of Silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-\u00df(1b)-treated MS patients. Inflammation. 2019;42(1):54\u201363. https:\/\/doi.org\/10.1007\/s10753-018-0872-x.","journal-title":"Inflammation"},{"key":"2256_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.996469","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Du S, Zhao L, Jain S, Sahay K, Rizvanov A, et al. Autoreactive lymphocytes in multiple sclerosis: pathogenesis and treatment target. Front Immunol. 2022;13:996469. https:\/\/doi.org\/10.3389\/fimmu.2022.996469.","journal-title":"Front Immunol"},{"key":"2256_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.817473","volume":"13","author":"AHS Heng","year":"2022","unstructured":"Heng AHS, Han CW, Abbott C, McColl SR, Comerford I. Chemokine-driven migration of pro-inflammatory CD4(+) T cells in CNS autoimmune disease. Front Immunol. 2022;13:817473. https:\/\/doi.org\/10.3389\/fimmu.2022.817473.","journal-title":"Front Immunol"},{"key":"2256_CR109","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767\u2013811. https:\/\/doi.org\/10.1146\/annurev.immunol.18.1.767.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2256_CR110","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s1074-7613(00)00034-0","volume":"13","author":"AB Bakker","year":"2000","unstructured":"Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, McNeil T, et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. 2000;13(3):345\u201353. https:\/\/doi.org\/10.1016\/s1074-7613(00)00034-0.","journal-title":"Immunity"},{"issue":"3","key":"2256_CR111","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s1074-7613(00)00035-2","volume":"13","author":"E Tomasello","year":"2000","unstructured":"Tomasello E, Desmoulins PO, Chemin K, Guia S, Cremer H, Ortaldo J, et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP\/DAP12 loss-of-function mutant mice. Immunity. 2000;13(3):355\u201364. https:\/\/doi.org\/10.1016\/s1074-7613(00)00035-2.","journal-title":"Immunity"},{"issue":"3","key":"2256_CR112","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.nrleng.2021.10.010","volume":"39","author":"EJ Ramos-Gonz\u00e1lez","year":"2024","unstructured":"Ramos-Gonz\u00e1lez EJ, Bitzer-Quintero OK, Ortiz G, Hern\u00e1ndez-Cruz JJ, Ram\u00edrez-Jirano LJ. Relationship between inflammation and oxidative stress and its effect on multiple sclerosis. Neurolog\u00eda (English Edition). 2024;39(3):292\u2013301. https:\/\/doi.org\/10.1016\/j.nrleng.2021.10.010.","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"4","key":"2256_CR113","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","journal-title":"Cell"},{"issue":"22","key":"2256_CR114","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185(22):4135-52.e22. https:\/\/doi.org\/10.1016\/j.cell.2022.09.030.","journal-title":"Cell"},{"issue":"7","key":"2256_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, et al. Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis. 2019;10(7):487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9.","journal-title":"Cell Death Dis"},{"issue":"8006","key":"2256_CR116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB, et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature. 2024;628(8006):195\u2013203. https:\/\/doi.org\/10.1038\/s41586-024-07167-9.","journal-title":"Nature"},{"issue":"Pt 2","key":"2256_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113476","volume":"143","author":"Y Nan","year":"2024","unstructured":"Nan Y, Ni S, Liu M, Hu K. The emerging role of microglia in the development and therapy of multiple sclerosis. Int Immunopharmacol. 2024;143(Pt 2):113476. https:\/\/doi.org\/10.1016\/j.intimp.2024.113476.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2256_CR118","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","volume":"56","author":"L Zhong","year":"2023","unstructured":"Zhong L, Sheng X, Wang W, Li Y, Zhuo R, Wang K, et al. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration. Immunity. 2023;56(8):1794-808.e8. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.016.","journal-title":"Immunity"},{"issue":"4","key":"2256_CR119","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell. 2017;170(4):649-63.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023.","journal-title":"Cell"},{"issue":"4","key":"2256_CR120","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140(4):513\u201334. https:\/\/doi.org\/10.1007\/s00401-020-02193-z.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2256_CR121","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s42255-021-00341-7","volume":"3","author":"M Bosch-Queralt","year":"2021","unstructured":"Bosch-Queralt M, Cantuti-Castelvetri L, Damkou A, Schifferer M, Schlepckow K, Alexopoulos I, et al. Diet-dependent regulation of TGF\u03b2 impairs reparative innate immune responses after demyelination. Nat Metab. 2021;3(2):211\u201327. https:\/\/doi.org\/10.1038\/s42255-021-00341-7.","journal-title":"Nat Metab"},{"key":"2256_CR122","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/978-3-031-55529-9_25","volume":"37","author":"BP Hammond","year":"2024","unstructured":"Hammond BP, Panda SP, Kaushik DK, Plemel JR. Microglia and Multiple Sclerosis. Adv Neurobiol. 2024;37:445\u201356. https:\/\/doi.org\/10.1007\/978-3-031-55529-9_25.","journal-title":"Adv Neurobiol"},{"issue":"1","key":"2256_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17999-3","volume":"7","author":"E Castillo","year":"2017","unstructured":"Castillo E, Leon J, Mazzei G, Abolhassani N, Haruyama N, Saito T, et al. Comparative profiling of cortical gene expression in Alzheimer\u2019s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation. Sci Rep. 2017;7(1):17762. https:\/\/doi.org\/10.1038\/s41598-017-17999-3.","journal-title":"Sci Rep"},{"issue":"3","key":"2256_CR124","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41380-018-0255-6","volume":"24","author":"JV Haure-Mirande","year":"2019","unstructured":"Haure-Mirande JV, Wang M, Audrain M, Fanutza T, Kim SH, Heja S, et al. Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in cerebral A\u03b2 amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing A\u03b2 burden. Mol Psychiatry. 2019;24(3):431\u201346. https:\/\/doi.org\/10.1038\/s41380-018-0255-6.","journal-title":"Mol Psychiatry"},{"key":"2256_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci. 2018;12:206. https:\/\/doi.org\/10.3389\/fncel.2018.00206.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"2256_CR126","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1211851.","journal-title":"N Engl J Med"},{"issue":"3","key":"2256_CR127","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153(3):707\u201320. https:\/\/doi.org\/10.1016\/j.cell.2013.03.030.","journal-title":"Cell"},{"issue":"1","key":"2256_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00552-w","volume":"17","author":"JV Haure-Mirande","year":"2022","unstructured":"Haure-Mirande JV, Audrain M, Ehrlich ME, Gandy S. Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: transduction of physiological and pathological signals across TREM2. Mol Neurodegener. 2022;17(1):55. https:\/\/doi.org\/10.1186\/s13024-022-00552-w.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"2256_CR129","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-Amyloid that mediates microglial function. Neuron. 2018;97(5):1023-31.e7. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.031.","journal-title":"Neuron"},{"issue":"3","key":"2256_CR130","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017;214(3):597\u2013607. https:\/\/doi.org\/10.1084\/jem.20160844.","journal-title":"J Exp Med"},{"issue":"5","key":"2256_CR131","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, et al. Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron. 2018;97(5):1032-48.e5. https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002.","journal-title":"Neuron"},{"issue":"11","key":"2256_CR132","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14(11):667\u201375. https:\/\/doi.org\/10.1038\/s41582-018-0072-1.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2256_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00830-3","volume":"20","author":"H Martiskainen","year":"2025","unstructured":"Martiskainen H, Willman RM, Harju P, Heikkinen S, Heiskanen M, M\u00fcller SA, et al. Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u2019s disease. Mol Neurodegener. 2025;20(1):50. https:\/\/doi.org\/10.1186\/s13024-025-00830-3.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"2256_CR134","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1212\/wnl.59.7.1105","volume":"59","author":"T Kondo","year":"2002","unstructured":"Kondo T, Takahashi K, Kohara N, Takahashi Y, Hayashi S, Takahashi H, et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms. Neurology. 2002;59(7):1105\u20137. https:\/\/doi.org\/10.1212\/wnl.59.7.1105.","journal-title":"Neurology"},{"issue":"3","key":"2256_CR135","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1172\/jci16923","volume":"111","author":"T Kaifu","year":"2003","unstructured":"Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, Kaji M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest. 2003;111(3):323\u201332. https:\/\/doi.org\/10.1172\/jci16923.","journal-title":"J Clin Invest"},{"issue":"1","key":"2256_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02671-z","volume":"20","author":"N Beckmann","year":"2023","unstructured":"Beckmann N, Neuhaus A, Zurbruegg S, Volkmer P, Patino C, Joller S, et al. Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model. J Neuroinflammation. 2023;20(1):29. https:\/\/doi.org\/10.1186\/s12974-022-02671-z.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2256_CR137","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nri2765","volume":"10","author":"A M\u00f3csai","year":"2010","unstructured":"M\u00f3csai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387\u2013402. https:\/\/doi.org\/10.1038\/nri2765.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2256_CR138","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","volume":"188","author":"K Otero","year":"2012","unstructured":"Otero K, Shinohara M, Zhao H, Cella M, Gilfillan S, Colucci A, et al. TREM2 and \u03b2-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J Immunol. 2012;188(6):2612\u201321. https:\/\/doi.org\/10.4049\/jimmunol.1102836.","journal-title":"J Immunol"},{"issue":"3","key":"2256_CR139","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41590-022-01403-y","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Tada M, Cai Z, Andhey PS, Swain A, Miller KR, et al. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia. Nat Immunol. 2023;24(3):545\u201357. https:\/\/doi.org\/10.1038\/s41590-022-01403-y.","journal-title":"Nat Immunol"},{"key":"2256_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00191","volume":"10","author":"C Arcuri","year":"2017","unstructured":"Arcuri C, Mecca C, Bianchi R, Giambanco I, Donato R. The pathophysiological role of microglia in dynamic surveillance, phagocytosis and structural remodeling of the developing CNS. Front Mol Neurosci. 2017;10:191. https:\/\/doi.org\/10.3389\/fnmol.2017.00191.","journal-title":"Front Mol Neurosci"},{"key":"2256_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189959","author":"A De Palma","year":"2021","unstructured":"De Palma A, Agresta AM, Viglio S, Rossi R, D\u2019Amato M, Di Silvestre D, et al. A shotgun proteomic platform for a global mapping of lymphoblastoid cells to gain insight into Nasu-Hakola Disease. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22189959.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2256_CR142","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","volume":"19","author":"WM Song","year":"2018","unstructured":"Song WM, Colonna M. The identity and function of microglia in neurodegeneration. Nat Immunol. 2018;19(10):1048\u201358. https:\/\/doi.org\/10.1038\/s41590-018-0212-1.","journal-title":"Nat Immunol"},{"issue":"2","key":"2256_CR143","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","volume":"36","author":"A Gierut","year":"2010","unstructured":"Gierut A, Perlman H, Pope RM. Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am. 2010;36(2):271\u201396. https:\/\/doi.org\/10.1016\/j.rdc.2010.03.004.","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"2256_CR144","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41584-025-01323-9","volume":"22","author":"M Rauner","year":"2026","unstructured":"Rauner M, Bozec A. Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis. Nat Rev Rheumatol. 2026;22(1):42\u201361. https:\/\/doi.org\/10.1038\/s41584-025-01323-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"2256_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/ar4088","volume":"14","author":"TN Crotti","year":"2012","unstructured":"Crotti TN, Dharmapatni AA, Alias E, Zannettino AC, Smith MD, Haynes DR. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthritis Res Ther. 2012;14(6):R245. https:\/\/doi.org\/10.1186\/ar4088.","journal-title":"Arthritis Res Ther"},{"issue":"7195","key":"2256_CR146","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nature07013","volume":"453","author":"ST Chen","year":"2008","unstructured":"Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453(7195):672\u20136. https:\/\/doi.org\/10.1038\/nature07013.","journal-title":"Nature"},{"issue":"11","key":"2256_CR147","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1172\/jci57682","volume":"121","author":"R Cheung","year":"2011","unstructured":"Cheung R, Shen F, Phillips JH, McGeachy MJ, Cua DJ, Heyworth PG, et al. Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice. J Clin Invest. 2011;121(11):4446\u201361. https:\/\/doi.org\/10.1172\/jci57682.","journal-title":"J Clin Invest"},{"key":"2256_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086105","author":"DY Chen","year":"2014","unstructured":"Chen DY, Yao L, Chen YM, Lin CC, Huang KC, Chen ST, et al. A potential role of myeloid DAP12-associating lectin (MDL)-1 in the regulation of inflammation in Rheumatoid Arthritis patients. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0086105.","journal-title":"PLoS ONE"},{"issue":"12","key":"2256_CR149","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1073\/pnas.0900463106","volume":"106","author":"M Inui","year":"2009","unstructured":"Inui M, Kikuchi Y, Aoki N, Endo S, Maeda T, Sugahara-Tobinai A, et al. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc Natl Acad Sci U S A. 2009;106(12):4816\u201321. https:\/\/doi.org\/10.1073\/pnas.0900463106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2256_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040498","volume":"17","author":"D Fan","year":"2016","unstructured":"Fan D, He X, Bian Y, Guo Q, Zheng K, Zhao Y, et al. Triptolide modulates TREM-1 signal pathway to inhibit the inflammatory response in rheumatoid arthritis. Int J Mol Sci. 2016;17(4):498. https:\/\/doi.org\/10.3390\/ijms17040498.","journal-title":"Int J Mol Sci"},{"key":"2256_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.733992","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:733992. https:\/\/doi.org\/10.3389\/fcimb.2022.733992.","journal-title":"Front Cell Infect Microbiol"},{"key":"2256_CR152","doi-asserted-by":"publisher","first-page":"1081176","DOI":"10.3389\/fmolb.2022.1081176","volume":"9","author":"R Yarani","year":"2022","unstructured":"Yarani R, Palasca O, Doncheva NT, Anthon C, Pilecki B, Svane CAS, et al. Cross-species high-resolution transcriptome profiling suggests biomarkers and therapeutic targets for ulcerative colitis. Front Mol Biosci. 2022;9:1081176. https:\/\/doi.org\/10.3389\/fmolb.2022.1081176.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"2256_CR153","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbad025","volume":"6","author":"F Zhu","year":"2023","unstructured":"Zhu F, Jing D, Zhou H, Hu Z, Wang Y, Jin G, et al. Blockade of Syk modulates neutrophil immune-responses via the mTOR\/RUBCNL-dependent autophagy pathway to alleviate intestinal inflammation in Ulcerative Colitis. Precis Clin Med. 2023;6(4):pbad025. https:\/\/doi.org\/10.1093\/pcmedi\/pbad025.","journal-title":"Precis Clin Med"},{"issue":"1","key":"2256_CR154","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/ibd\/izx031","volume":"24","author":"M Biagioli","year":"2017","unstructured":"Biagioli M, Mencarelli A, Carino A, Cipriani S, Marchian\u00f2 S, Fiorucci C, et al. Genetic and pharmacological dissection of the role of spleen tyrosine kinase (Syk) in intestinal inflammation and immune dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;24(1):123\u201335. https:\/\/doi.org\/10.1093\/ibd\/izx031.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"2256_CR155","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/ecco-jcc\/jjv114","volume":"9","author":"G Can","year":"2015","unstructured":"Can G, Ayvaz S, Can H, Demirtas S, Aksit H, Yilmaz B, et al. The Syk inhibitor Fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis. J Crohns Colitis. 2015;9(10):907\u201317. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv114.","journal-title":"J Crohns Colitis"},{"key":"2256_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114122","volume":"148","author":"L Chen","year":"2025","unstructured":"Chen L, Zhu F, Gao X, Yang Y, Jin G, Zhou Y, et al. Spleen tyrosine kinase aggravates intestinal inflammation through regulating inflammatory responses of macrophage in ulcerative colitis. Int Immunopharmacol. 2025;148:114122. https:\/\/doi.org\/10.1016\/j.intimp.2025.114122.","journal-title":"Int Immunopharmacol"},{"key":"2256_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054311","author":"AV Markov","year":"2023","unstructured":"Markov AV, Savin IA, Zenkova MA, Sen\u2019kova AV. Identification of novel core genes involved in malignant transformation of inflamed colon tissue using a computational biology approach and verification in murine models. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054311.","journal-title":"Int J Mol Sci"},{"issue":"26","key":"2256_CR158","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/nejm199406303302608","volume":"330","author":"JA Mills","year":"1994","unstructured":"Mills JA. Systemic lupus erythematosus. N Engl J Med. 1994;330(26):1871\u20139. https:\/\/doi.org\/10.1056\/nejm199406303302608.","journal-title":"N Engl J Med"},{"issue":"4","key":"2256_CR159","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98(4):479\u201387. https:\/\/doi.org\/10.1189\/jlb.4RU0315-081RR.","journal-title":"J Leukoc Biol"},{"key":"2256_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645478","volume":"12","author":"M Humbel","year":"2021","unstructured":"Humbel M, Bellanger F, Fluder N, Horisberger A, Suffiotti M, Fenwick C, et al. Restoration of NK cell cytotoxic function with Elotuzumab and Daratumumab promotes elimination of circulating plasma cells in patients with SLE. Front Immunol. 2021;12:645478. https:\/\/doi.org\/10.3389\/fimmu.2021.645478.","journal-title":"Front Immunol"},{"key":"2256_CR161","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.195170","author":"N Fluder","year":"2026","unstructured":"Fluder N, Humbel M, Recazens E, Jourdain AA, Ribi C, Tsokos G, et al. Mitochondrial dysfunction drives natural killer cell dysfunction in Systemic Lupus Erythematosus. JCI Insight. 2026. https:\/\/doi.org\/10.1172\/jci.insight.195170.","journal-title":"JCI Insight"},{"issue":"4","key":"2256_CR162","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaut.2004.09.003","volume":"23","author":"S Toyabe","year":"2004","unstructured":"Toyabe S, Kaneko U, Uchiyama M. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations. J Autoimmun. 2004;23(4):371\u20138. https:\/\/doi.org\/10.1016\/j.jaut.2004.09.003.","journal-title":"J Autoimmun"},{"issue":"8","key":"2256_CR163","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20160189","volume":"213","author":"H Schmitt","year":"2016","unstructured":"Schmitt H, Sell S, Koch J, Seefried M, Sonnewald S, Daniel C, et al. Siglec-H protects from virus-triggered severe systemic autoimmunity. J Exp Med. 2016;213(8):1627\u201344. https:\/\/doi.org\/10.1084\/jem.20160189.","journal-title":"J Exp Med"},{"issue":"6","key":"2256_CR164","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2005-09-3746","volume":"107","author":"AL Blasius","year":"2006","unstructured":"Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 2006;107(6):2474\u20136. https:\/\/doi.org\/10.1182\/blood-2005-09-3746.","journal-title":"Blood"},{"key":"2256_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698420","volume":"12","author":"N Szumilas","year":"2021","unstructured":"Szumilas N, Corneth OBJ, Lehmann CHK, Schmitt H, Cunz S, Cullen JG, et al. Siglec-H-deficient mice show enhanced Type I IFN responses, but do not develop autoimmunity after Influenza or LCMV infections. Front Immunol. 2021;12:698420. https:\/\/doi.org\/10.3389\/fimmu.2021.698420.","journal-title":"Front Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02256-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:17:12Z","timestamp":1778059032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02256-z","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"110"}}